載入...
Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience
Purpose: The neoadjuvant use of pertuzumab and trastuzumab with chemotherapy improves the pathologic complete response (pCR) in early HER2+ breast cancer. The aim of this study was to determine the pCR rate obtained with dual HER2 blockade in routine clinical practice. The secondary and tertiary obj...
Na minha lista:
| 發表在: | Pathol Oncol Res |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262177/ https://ncbi.nlm.nih.gov/pubmed/34257621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.1609785 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|